Lifeboat Foundation

In an era of maturing artificial intelligence technology, what does the future of the corporation look like? Will the rise of robots help us do our jobs better, or harm them? This dynamic has become a mainstay of the dialogue around AI, with voices from technology visionaries such as Bill Gates and Stephen Hawking weighing in.

But at Fortune’s Most Powerful Women International Summit in Hong Kong on Tuesday, leaders at two of the world’s most powerful tech giants pushed back on those concerns. AI is intended to help—not hinder—the human workforce, they said.

“AI is actually not new for us,” said Vanitha Narayanan, chairman of IBM India, whose Watson supercomputer has risen to global acclaim. But “technology always comes way ahead of policy.”

Continue reading “Google and IBM: We Want Artificial Intelligence to Help You, Not Replace You” »

Apple’s Macs are losing market share in the critical education market, as Google and Microsoft continue to grow their share.

An experimental vaccine therapy left HIV patients without any detectable virus.

Silicon Valley engineers and financiers make up the lion’s share of the movement.

What makes a cluster of cells become a liver, or a muscle? How do our genes give rise to proteins, proteins to cells, and cells to tissues and organs?

The incredible complexity of how these biological systems interact boggles the mind—and drives the work of biomedical scientists around the world.

But a pair of mathematicians has introduced a new way of thinking about these concepts that may help set the stage for better understanding of our bodies and other living things.

The tale of a teen physics prodigy.

Aging isn’t a one-way street, finds a new study in which aged mice had their youthfulness restored.

The new research, led by nanoengineering professor Shaochen Chen, addresses one of the biggest challenges in tissue engineering: creating lifelike tissues and organs with functioning vasculature — networks of blood vessels that can transport blood, nutrients, waste and other biological materials — and do so safely when implanted inside the body.

Researchers from other labs have used different 3D printing technologies to create artificial blood vessels. But existing technologies are slow, costly and mainly produce simple structures, such as a single blood vessel — a tube, basically. These blood vessels also are not capable of integrating with the body’s own vascular system.

“Almost all tissues and organs need blood vessels to survive and work properly. This is a big bottleneck in making organ transplants, which are in high demand but in short supply,” said Chen, who leads the Nanobiomaterials, Bioprinting, and Tissue Engineering Lab at UC San Diego. “3D bioprinting organs can help bridge this gap, and our lab has taken a big step toward that goal.”

Continue reading “Nanoengineers 3D print biomimetic blood vessel networks” »

Austen Heinz was Founder and CEO of Cambrian Genomics. With his company, Austen hoped to change the world by democratizing access to DNA through cost-effective and fast DNA laser printing. Austen will always be remembered as one of the most passionate, creative people to have spoken at Draper University.

For more great content, check out:
Videos and livestreams: http://www.drapertv.com
Residential program: http://www.draperuniversity.com
Online Courses: http://www.courses.drapertv.com

Continue reading “Creating Animals from Imagination (And DNA Sequencing)” »